US$ 25.90
dr reddy's semaglutide gets regulatory nod to sell generic Ozempic in India, targets 12 million pens in first year Dr Reddy's Flags Semaglutide Supply
Description
Real-world data plays a critical role in helping to evaluate how therapies perform across broader, more diverse populations in everyday care
pricing pressure, rising market competition and compounded tirzepatide risks, despite strong GLP-1 demand.
Reacts with Human, Mouse, Rat

For researchuse only.